Last update 13 Nov 2024

SLV-339

Overview

Basic Info

Drug Type
Enzyme
Synonyms
SLV 339, SLV-339, SLV339
Target
Lipase
Mechanism
Lipase stimulants
Therapeutic Areas
Digestive System Disorders
Active Indication-
Inactive Indication
Exocrine Pancreatic InsufficiencyPancreatitis, Chronic
Originator Organization
Solvay SASolvay SA
Active Organization-
Inactive Organization
Solvay Pharmaceuticals, Inc.Solvay Pharmaceuticals, Inc.Solvay SASolvay SANovozymes A/SNovozymes A/S
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with SLV-339
NCT00630279 / TerminatedPhase 2
A Multi-center, Single-blind, Parallel-design, Randomized, Placebo-controlled, Dose-ranging Study to Evaluate Oral Recombinant Microbial Lipase Efficacy in Patients With Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis
100 Clinical Results associated with SLV-339
Login to view more data
100 Translational Medicine associated with SLV-339
Login to view more data
100 Patents (Medical) associated with SLV-339
Login to view more data
100 Deals associated with SLV-339
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pancreatitis, ChronicPhase 2
CZ
Solvay Pharmaceuticals, Inc.Solvay Pharmaceuticals, Inc.
01 Feb 2008
Pancreatitis, ChronicPhase 2
DK
Solvay Pharmaceuticals, Inc.Solvay Pharmaceuticals, Inc.
01 Feb 2008
Pancreatitis, ChronicPhase 2
HU
Solvay Pharmaceuticals, Inc.Solvay Pharmaceuticals, Inc.
01 Feb 2008
Pancreatitis, ChronicPhase 2
LV
Solvay Pharmaceuticals, Inc.Solvay Pharmaceuticals, Inc.
01 Feb 2008
Pancreatitis, ChronicPhase 2
PL
Solvay Pharmaceuticals, Inc.Solvay Pharmaceuticals, Inc.
01 Feb 2008
Pancreatitis, ChronicPhase 2
RU
Solvay Pharmaceuticals, Inc.Solvay Pharmaceuticals, Inc.
01 Feb 2008
Pancreatitis, ChronicPhase 2
SE
Solvay Pharmaceuticals, Inc.Solvay Pharmaceuticals, Inc.
01 Feb 2008
Exocrine Pancreatic InsufficiencyPhase 2
CZ
Solvay Pharmaceuticals, Inc.Solvay Pharmaceuticals, Inc.
01 Feb 2008
Exocrine Pancreatic InsufficiencyPhase 2
DK
Solvay Pharmaceuticals, Inc.Solvay Pharmaceuticals, Inc.
01 Feb 2008
Exocrine Pancreatic InsufficiencyPhase 2
HU
Solvay Pharmaceuticals, Inc.Solvay Pharmaceuticals, Inc.
01 Feb 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free